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GDNF promotes hair formation and cutaneous wound
healing by targeting bulge stem cells
Thomas S. Lisse

1,2,3,5 ✉

, Manju Sharma1,5, Neda Vishlaghi2, Sri Ramulu Pullagura1,4 and Robert E. Braun1,4 ✉

Glial-cell-derived neurotrophic factor (GDNF) is a well-studied neuroregenerative factor; however, the degree to which it supports
hair formation and skin wound repair is not known. By using a Gfra1 (GDNF family receptor alpha 1) knock-in reporter mouse line,
GDNF signaling was found to occur within hair bulge stem cells (BSCs) during the initiation of the hair cycle and early stages of hair
formation after depilation. Both recombinant and transgene overexpression of GDNF promoted BSC colony growth, hair formation,
and skin repair after wounding through enhanced self-renewal of BSCs and commitment of BSC-derived progenitors into becoming
epidermal cells at the injury site. Conditional ablation of Gfra1 among BSCs impaired the onset of the hair cycle, while conditional
ablation of the GDNF family member signal transducer, Ret, within BSCs prevented the onset of the hair cycle and depilationinduced anagen development of hair follicles. Our ﬁndings reveal that GDNF promotes hair formation and wound repair and that
bulge stem cells are critical mediators of both.
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INTRODUCTION
Hair follicles (HFs) are formed through complex epithelial-mesenchymal
interactions. In mice, the morphogenic period of hair formation ends at
approximately postnatal day 14 (P14) when HFs establish a deﬁnitive
bulge stem cell (BSC) compartment1–3. BSCs are quiescent and serve as
a long-lived pool for regeneration of the lower portion of HFs during
cycle activation and injury4–6. BSCs retain methylated histones7, and
express several distinct molecular markers, namely CD34 and keratin 15
(K15)8. During the post-morphogenic period, the lower part of the HF
undergoes cyclic transformations of growth, involution, and quiescence.
These transitions are termed the anagen, catagen, and telogen stages,
respectively3. The anagen-to-catagen transition marks the end of the
active growth phase by deleting, via apoptosis, the old hair shaft. This
positions the remaining dermal papilla (Dp), which serves as an
inductive signaling center, within close proximity to BSCs to start a new
hair cycle upon activation. BSCs also contribute to the healing of
wounded skin. During cutaneous wounding of adult skin, a reservoir of
BSCs from pre-exiting follicles and/or the interfollicular epithelium (IFE)
display plasticity to either become transiently or permanently
committed to the neoepidermis of wounds and HFs9–15.
Glial-cell-line-derived neurotrophic factor (GDNF) was ﬁrst
identiﬁed and characterized as a potent neuroprotective and
axonal regenerative factor for subpopulations of dopaminergic16
and motor neurons17,18. Subsequently it was found to maintain
mammalian spermatogonial stem cell (SSC) self-renewal within the
testis19,20, and to regulate both renal organogenesis21 and enteric
neurogenesis22,23 in mice. GDNF elicits its biological effects
through a complex consisting of the RET proto-oncogene
transmembrane receptor tyrosine kinase and a glycosylphosphatidylinositol (GPI)-anchored cell surface co-receptor belonging to
the GDNF receptor alpha (GFRA) family18. Although there are four
GFRA family members, GDNF preferentially binds to GFRA1 to elicit
activation of its signaling cascade24. Several receptor-protein
tyrosine kinases can regulate the hair cycle25. The RET tyrosine
kinase has been implicated in the induction of melanogenesis to

provide pigment for HFs26, whereby follicular melanogenesis is
coupled to the anagen stage of the hair cycle27. Although the Gfra1
transcript was shown to be enriched in BSCs28,29, the functional
impact of GDNF signaling within BSCs on the hair cycle, and hair
and cutaneous wound healing after injury, is currently unknown.
The purpose of this study was to determine if GDNF can promote
hair formation and skin wound repair by targeting BSCs.

RESULTS
GDNF initiates the anagen stage of the hair cycle to promote hair
formation
In order to study the function of GDNF in promoting self-renewal
of spermatogonial stem cells, we had generated transgenic mice
that overexpressed Gdnf driven by the lysosomal proteinase
cathepsin L (Ctsl) gene promoter (herein referred to as Tg(CtslGdnf)) within somatic Sertoli cells20. Incidentally, one of the
unexpected phenotypes was a profound effect on hair follicle
formation in both male and female homozygous Tg(Ctsl-Gdnf)
mice (Fig. 1a, b). At 50-days of age, HFs in wild-type mice are kept
in the telogen resting stage of the hair cycle characterized by a
miniaturization in structure. In contrast, homozygous Tg(Ctsl-Gdnf)
mice exhibited anagen HFs characterized by increased growth of
the shaft diameter and entry into the hypodermis. GDNF was
found to be present predominantly within the interfollicular space
and in the vicinity of sebaceous glands of HFs in wild-type mice
(Supplementary Fig. 1). In comparison, homozygous Tg(Ctsl-Gdnf)
mice exhibited increased GDNF concentrated at the base of
sebaceous glands proximate the hair BSC compartment, and
sequestered in the interfollicular space (Fig. 1c and Supplementary
Fig. 1). Importantly, the expression pattern of GDNF in the HFs of
Tg(Ctsl-Gdnf) mice is consistent with the expression pattern of Ctsl
present within the uppermost bulge layers harboring the stem cell
reserve closest to sebaceous glands (Supplementary Fig. 2)29.
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Fig. 1 GDNF promotes hair formation. a GDNF overexpression in transgenic mice leads to increased hair formation. Right panels depict
Masson’s trichrome staining of skin sections (blue = dermal collagens, red = muscle and keratin). Scale bars = 200 µm. b Quantiﬁcation of the
number of anagen HFs per 2 mm skin section at P50. n = 5, male control +/+; n = 5, male Tg/Tg(Ctsl-GDNF), p ≤ 0.001; error bars = SEM, twoway ANOVA with Bonferroni post-hoc test. c Immunoﬂuorescence analysis of GDNF expression in skin. Hair follicle (HF). See also Figs. S1–2.
d GDNF promotes hair formation after depilation. Dorsal skins were wax depilated (outlined in white) and analyzed 4 days later. Top views of
the depilated skins (upper panels), and H&E-stained tissue sections (lower panels). Hair shaft (arrow). Scale bars = 200 µm. e GDNF promotes
the proliferative expansion of K15+ BSCs within HFs. Immunoﬂuorescence analysis depicting representative HFs (outlined in white) at start
(non-depilated; upper panels) and 1-day post depilation (lower panels). Magniﬁcations of Ki67+ proliferating K15+ BSCs (bracket). Hair follicles
(HF), hair germ (Hg). Scale bars = 20 µm. f qPCR analysis of GDNF-mediated hair formation 1 day after depilation. Two-tailed Student’s t-test
(p ≤ 0.05*≤0.001**≤0.001***), n = 3 skin samples per group; error bars = SEM. g BSCs puriﬁed from hair follicles using FACS. CD34+/CD49f+
puriﬁcation of BSCs (top). Quantiﬁcation of BSC colonies treated with either vehicle (PBS) or GDNF (100 ng/ml) at 3 or 6 days after plating
(middle). BSC colonies (bottom, arrows). Error bars = SEM, two-way ANOVA, n = 3, p < 0.001. Scale bar = 0.1 mm.

We investigated GDNF’s potential to regulate anagen induction
by ﬁrst monitoring responses to hair plucking (depilation) within
the dorsal region of mice. At 4-days post depilation (dpd), control
(+/+) animals exhibited early stage anagen HFs (Fig. 1d, left
panels). However, homozygous Tg(Ctsl-Gdnf) mice resulted in
elongated HFs with hair shafts and comparatively thicker skin (i.e.,
an indication of advanced anagen hair growth) by 4 dpd (Fig. 1d,
right panels). Next, we appraised the effects of GDNF overexpression on BSCs during depilation-induced hair formation.
Using immunoﬂuorescence (IF), we observed no obvious differences in the expression of K15 in the non-depilated pool of BSCs
between +/+ and homozygous Tg(Ctsl-Gdnf) HFs (Fig. 1e, top
panels). At 1 dpd in control mice, we observed the expected
proliferation (marked by Ki67) of hair germ cells (i.e., primed stem
cells located between the bulge and Dp cluster) with limited
proliferation of K15+ BSCs (Fig. 1e, left panels). In contrast,
homozygous Tg(Ctsl-Gdnf) HFs exhibited a proliferative expansion
and self-renewal of K15+ BSCs (Fig. 1e, right panels). The enhanced
replenishment of the depleted BSC pool by elevated GDNF was
validated using qPCR analysis, revealing a near-return of K15 mRNA
levels to non-depilated skin levels by 1 dpd (Fig. 1f). To further
npj Regenerative Medicine (2020) 13

validate the self-renewing capacity of GDNF, we performed in vitro
BSC colony formation assays using CD34+/CD49f+-puriﬁed BSCs
derived from wild-type mice treated with or without recombinant
GDNF (recGDNF). We observed a statistically signiﬁcant (p < 0.01)
increase in the size and growth rate of BSC colonies after treatment
with recGDNF in comparison to vehicle treatment (Fig. 1g). Lastly,
we ascertained if GDNF can activate anagen hair growth, per se, by
monitoring hair formation starting from rest (telogen) upon
administration of recGDNF to non-depilated 50-day-old C57BL/6J.
We observed a dose-dependent response of recGDNF on HF
formation and hallmarks of anagen (i.e., dermal thickening)
compared to PBS-injected controls (Fig. 2), suggesting that GDNF
can also activate hair BSCs in vivo to initiate anagen hair growth.
GDNF-responding cells are present within the hair follicle bulge
and dermal papillary compartments at distinct stages of the hair
cycle
To identify the GDNF-responding cells within the hair follicle, we
utilized a Gfra1 GFP reporter mouse line23. We generated
heterozygous mice that expressed the Gfra1 EGFP-knock-in allele
Published in partnership with the Australian Regenerative Medicine Institute
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(Gfra1tm2.1Jmi) in a ubiquitous manner by crossing Gfra1tm2.1Jmi
mice to β-actin (ACTB)-cre mice. The resultant offspring herein are
referred to as Gfra1EGFP/+. In this system, due to the ubiquitous
expression of ACTB-cre, the EGFP reporter is controlled by the
endogenous Gfra1 promoter in every cell. We ﬁrst monitored
GFRA1–EGFP expression within anagen II HFs and observed EGFP+
cells speciﬁcally within the bulge and Dp compartments (Fig. 3a,
b). In resting telogen II HFs, we observed EGFP+ cells within the
outer bulge compartment, but not within the Dp compartment
(Fig. 3c). These results were conﬁrmed using immunoﬂuorescence
analysis with antibodies against K15, GFRA1, and RET within HFs of
C57BL/6J mice (Supplementary Fig. 3).
To investigate GFRA1 expression during induction of anagen, we
monitored GFRA1–EGFP expression soon after hair depilation using
Gfra1EGFP/+ mice. At 1 dpd, we observed the expected reduction in
the amount of EGFP+ cells localized to the bulge compartment
(Fig. 3d, left 2 panels) compared to non-depilated HFs at rest
(Fig. 3c). At the onset of anagen 1 dpd, we observed no EGFP+ cells
localized to the Dp compartment (Fig. 3d, left 2 panels). At 2 dpd, a
stage in which the Dp compartment ﬁrst becomes encased by
rapidly proliferating HF matrix cells3, we observed the expected
downward growth of HFs into the dermis3, and the continued
detection of EGFP+ cells within the bulge compartment alone. These
results are consistent with our GDNF overexpression studies
monitoring hair bulge stem cell expansion (Fig. 1e, g). At 4 dpd,
the presence of EGFP+ cells in the bulge compartment persisted;
however, at this time point we also detected GFRA1–EGFP
expression within the Dp compartment of maturing anagen HFs
(Fig. 3d, right panel). Lastly, we analyzed the distribution of
GFRA1–EGFP+ cells within individual HFs during the telogen and
anagen stages of the hair cycle. We observed a statistically
signiﬁcant difference (Fisher’s exact test) in the GFRA1–EGFP cellular
distribution pattern within HFs in which GFRA1 is expressed in
dermal papillary cells only during the anagen stage (Fig. 3e).
However, GFRA1–EGFP+ cells are present within the HF bulge
compartment in both telogen and anagen stages. Overall, these
results are consistent with a model in which GDNF-responding cells
within the bulge compartment and the DP are involved in the
induction of anagen and growth of HFs, respectively (Fig. 3f).

Fig. 2 Recombinant GDNF initiates the anagen growth stage of
the hair cycle. Dorsal skins of P50 C57BL/6J mice were injected with
a single dose of 10–50 µg recGDNF or vehicle (PBS). Asterisk
represents the HF in the expanded inset. Surface views of the
vehicle and recGDNF-treated animals reveal prominent hair growth
after rec-GDNF treatment only (lower panels). Panniculus carnosus
(PC). Scale bars = 200 µm.
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RET signaling within BSCs is required for the initiation of the hair
cycle and depilation-induced hair regeneration
To study the role of downstream signaling by GDNF during the
hair cycle and depilation, we conditionally deleted the signal
transducing receptor, Ret, speciﬁcally within BSCs by generating
K15-CrePR1:Retﬂox/ﬂox mice (Fig. 4a). In this genetic model system,
upon progesterone antagonist mifepristone exposure (topical 1%
synthetic RU486), Cre recombinase is expressed in K15+ BSCs to
initiate Cre-mediated excision of the ﬂoxed exons 14 and 15 of the
RET kinase domain to generate non-functional RET30. As expected,
in control K15-CrePR1:Ret+/+ mice we observed underlying
pigmented skin and HFs at the second anagen stage (P29) of
the hair cycle through histological means that also incorporated
an ultimate 3D imaging of solvent-cleared organs (uDISCO) wholemount clearing method (Fig. 4b, lower right panel)31. At 4 dpd (i.e.,
starting at P25), in control animals we observed the expected
regrowth of anagen HFs (Fig. 4b, upper right panel). However,
when Ret was conditionally deleted in BSCs during telogen (P1921), the HFs remained at rest and failed to launch into the anagen
hair cycle by P29 (Fig. 4c, lower right panel). Furthermore, Ret
ablation within BSCs prevented the reconstitution of the lower HF
after depilation (Fig. 4c, upper right panel). Histomorphometric
analysis revealed a statistically signiﬁcant decrease in the number
of anagen HFs present both after depilation and at P29 within K15Cre:Retﬂox/ﬂox animals versus controls (Fig. 4d). qPCR analysis
comparing 4 dpd skin samples derived from K15-CrePR1:Retﬂox/ﬂox
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Fig. 3 Temporal and spatial expression of GFRA1 dictates the function of GDNF-responding cells within hair follicles. a Schema depicting
the morphogenic and post-morphogenic stages of the murine hair cycle. b GFRA1–EGFP is expressed within cells of the bulge (Bg) and dermal
papillary (Dp) compartments of anagen HFs from Gfra1EGFP/+ mice. Scale bar = 200 µm (left panel). Scale bar = 50 µm (bulge, shaft, Dp panels).
Sebaceous gland (Sg). See also Fig. S3. c GFRA1–EGFP is expressed within cells of the bulge (Bg) compartment but not within the dermal
papillary (Dp) compartment of telogen HFs from Gfra1EGFP/+ mice. Bars = 20 µm. Sebaceous gland (Sg). d GDNF targets bulge (Bg) cells but not
dermal papillary (Dp) cells of hair follicles during the early onset of hair growth. Time-course depilation analysis reveals that GDNF-responding
cells are restricted to the bulge (Bg) compartment during the early stages of anagen induction (i.e., 1–2 days post depilation). However, by 4days post depilation, GFRA1–EGFP becomes expressed within both Bg cells, and Dp cells that have become encased by matrix cells. At higher
magniﬁcation, GDNF-responding cells also include dermal cap (Dc) cells at the base of Dp cells. Scale bars = 20 µm. Sebaceous gland (Sg).
e Distribution of GFRA1–EGFP+ cells within hair follicles during telogen and anagen. Fisher’s exact test, two-sided, p = 0.0005. Dermal papilla
(DP). f Model depicting GDNF targeting of BSCs during the early stages of hair formation.

mice versus control samples in anagen conﬁrmed the reduction in
Ret and K15 transcripts after Ret deletion, and absence of mature
HFs and differentiated cuticular keratinocytes through reduced
Krt40 (keratin 40) mRNA levels (Fig. 4e). The qPCR analysis also
revealed enhanced WNT (i.e., as shown by increased Lef1 and
decreased Dkk2 expression) and reduced BMP (i.e., as evidenced
by reduced Bmp4/Bmpr1a) signaling within RET-deﬁcient skin
(Fig. 4e), suggesting a comparable inhibition in the hair cycle.
Interestingly, despite the BSC-speciﬁc RET-mediated defect in hair
formation after depilation, individual HFs did retain melanin
production (Fig. 4c, upper right panel, inset), presumably due to
intact RET tyrosine kinase signaling within melanocytes26. As
expected in K15-CrePR1:Ret+/+ control skin, immunoﬂuorescence
analysis revealed K15 expression predominantly within expanding
BSCs along the proximal portion of actively growing HFs in
depilated samples (Fig. 4f, left panel). However, BSC-speciﬁc Ret
npj Regenerative Medicine (2020) 13

ablation resulted in punctate expression of K15 in addition to
areas void of any K15 expression among individual hair follicles
after depilation (Fig. 4f, right panel). Certain hair follicles also
entirely lacked K15-expressing BSCs after depilation, suggesting a
range of BSC effects upon Ret ablation (Fig. 4f, right panel). During
the anagen stage of the hair cycle (P29), we observed the
expected clusters of K15+ BSCs within control HFs (Fig. 4g, left
panel). However, in K15-CrePR1:Retﬂox/ﬂox HFs, we observed
reduced numbers of K15+ cells within individual HFs at the
expected anagen stage of the hair cycle (Fig. 4g, right panel).
These results suggest that RET signaling within BSCs is required to
germinate the lower HF to the next anagen stage.
In order to study the role of GFRA1, one of the RET co-receptors
of GDNF, speciﬁcally within BSCs, we generated K15-CrePR1:
Gfra1ﬂox/ﬂox mice32 (Fig. 4h). To ablate Gfra1, we topically applied
1% RU486 and then monitored hair growth at the expected
Published in partnership with the Australian Regenerative Medicine Institute
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Fig. 4 RET signaling in BSCs is required for anagen induction and depilation-induced hair formation. a Conditional deletion of Ret and
Gfra1 within BSCs. b Regrowth of HFs in control mice after depilation and demonstration of presence of anagen HFs at P29. Outlined in white
are the uDISCO-cleared regions used for analysis. The hair cycle region was shaved immediately before imaging and tissue collection. H&E
staining of the regions are shown in the insets. Dep (depilated). c Severe hair phenotypes in BSC-speciﬁc Ret-deleted mice after depilation and
at P29. uDISCO-cleared depilated skin samples lack mature HFs that retains pigmentation (inset) (upper right panel). uDISCO-cleared skin
samples at P29 depict failure of HFs to transition into the anagen stage (lower right panel). H&E staining of the regions are shown in the insets.
d Quantiﬁcation of the number of anagen HFs present within histological skin sections at 4-days post depilation and at P29. n = 4, male
control K15-CrePR1+:Ret+/+; n = 4, male mutant K15-CrePR1+:Retﬂox/ﬂox; ***p ≤ 0.001; error bars = SEM, two-way ANOVA with Bonferroni posthoc test. e qPCR analysis at 4-days post depilation. Data represents K15-CrePR1+:Retﬂox/ﬂox versus K15-CrePR1+:Ret+/+ depilated skin samples.
n = 4–5 male skin samples per group. f K15 expression in control and BSC-speciﬁc Ret-deﬁcient skin at 4-days post depilation. K15 expression
within the BSC population (arrows) in control (left panel) and Ret-deﬁcient (right panel) hair follicles shows loss of K15+ cells after Ret ablation.
Scale bars = 200 µm. g K15 expression in control and BSC-speciﬁc Ret-deﬁcient skin during anagen at P29. BSC population (arrows) in control
(left panel) and Ret-deﬁcient (right panel) hair follicles shows loss of K15+ cells after Ret ablation. Scale bars = 200 µm. h Conditional deletion
of Gfra1 within BSCs. H&E-stained skin sections at 9 days post Gfra1 ablation(top panel). Arrows depict delayed encapsulation of dermal
papillae upon Gfra1 ablation within BSCs. Quantiﬁcation of the skin thickness from the epidermis to the underlying panniculus carnosus
muscle (lower panel). n = 4, male control K15-CrePR1-:Gfra1ﬂox/ﬂox; n = 3, male conditional knockout K15-CrePR1+:Gfra1ﬂox/ﬂox; p ≤ 0.05; error
bars = SEM, Student t-test. PCR conﬁrmation of deletion of the Gfra1 allele after RU486 treatment (lower right panel).

anagen stage. Compared to control (Gfra1ﬂox/ﬂox), Gfra1 ablation
within BSCs resulted in a suppression, but not prevention of hair
growth as reﬂected by a statistically signiﬁcant decrease in skin
thickness and presence of shorter HFs (Fig. 4h). Furthermore, in
comparison to control HFs, dermal papillae were not entirely
encapsulated upon Gfra1 ablation, suggesting a delay in the hair
cycle3 (Fig. 4h, arrows). These results suggest that alternative coreceptors in combination with GFRa1 are likely involved in
initiating the hair cycle mediated by downstream RET signaling.
RET signaling within interfollicular epidermal keratinocytes and
outer epithelial cells of hair follicles is not required for hair cycle
progression and plucking-induced anagen development
In order to further characterize the cellular speciﬁcity of RET
signaling during HF cycling and induced anagen development, we
conditionally ablated Ret within both interfollicular basal epidermal keratinocytes and cells that make up the outer epithelial layer
of HFs33. These cells express keratin 14 (K14) and play important
roles in maintaining the lipid barrier as well as anagen
development of HFs34. To ablate Ret within basal epidermal
keratinocytes and outer epithelial cells of HFs, we generated
K14CreERT:Retﬂox/ﬂox mice and induced CRE-mediated recombination by administration of tamoxifen (Fig. 5a). At 11-days after
synchronized anagen induction by wax depilation, we observed
Published in partnership with the Australian Regenerative Medicine Institute

no difference in hair shaft formation as a macroscopic indicator of
advanced anagen development between control and experimental K14-Ret-mutant animals (Fig. 5b, upper left panels). Similarly,
histological analysis revealed that anagen progression was no
different between control and experimental K14-Ret-mutant
animals after depilation (Fig. 5b, upper right panels). Changes in
the natural hair cycle were also investigated after Ret ablation
within K14-postivie cells. Once again, we observed no difference
in natural anagen development of HFs following tamoxifen
treatment between control or K14-Ret-mutant mice both at the
macroscopic and microscopic levels (Fig. 5b, lower panels). These
observations were conﬁrmed by quantifying the thickness of the
skin, which is an indicator of the degree of anagen progression3
(Fig. 5c). Lastly, Cre-mediated deletion of the ﬂoxed Ret allele was
conﬁrmed via deletion PCR using harvested skin tissues (Fig. 5d).
Overall, our data show that RET signaling within interfollicular
basal epidermal keratinocytes and outer epithelial cells of HFs is
not required for hair cycle progression and induced anagen
development in postnatal mice.
GDNF accelerates skin wound repair and healing with enhanced
hair formation
Given the interrelationship between hair follicles and cutaneous
wound repair and healing9, we investigated the effects of GDNF
npj Regenerative Medicine (2020) 13
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Fig. 5 Ret deletion within K14-expressing epithelial cells does not affect onset of anagen or induced anagen development after
depilation. a Overall experimental design to study RET signaling within K14-expressing cells during the start of the hair cycle and following
plucking-induced anagen development. b Macroscopic and microscopic H&E analysis of hair follicles after Ret ablation in K14+ cells. In the
upper left panels, depilated regions of the animals are marked by dashed lines. In the lower left panels, unperturbed skins were used to assess
the effect of Ret ablation on the hair cycle, and only shaved during imaging and tissue collection at P34. H&E sections are in the right panels.
Bars = 200 μm. c Quantitative analysis of Ret ablation within K14+ cells. Skin thickness was accessed by measuring the distance from the
epidermis to the underlying panniculus carnosus muscle. n = 3 male K14-CreERT+:Ret+/+ and K14-CreERT+:Retﬂox/ﬂox mice per group. error
bars = SEM, Student t-test. d Cre-mediated excision of exons 14–15 of Ret after tamoxifen treatment. PCR was used to determine Ret deletion
in the skin. Ret deletion was observed only in tamoxifen-treated K14-CreERT+:Retﬂox/ﬂox and K14CreERT+:Retﬂox/+ mice (red boxes).

toward repair and healing of 3 mm full-thickness truncal wounds
in mice.
To control for increased cellularity due to GDNF overexpression
in the homozygous state at the start of the experiments (Fig. 1a),
we performed wound healing assays using hemizygous Tg(CtslGdnf)/0 mice. Hemizygous Tg(Ctsl-Gdnf)/0 P19 and P50 mice show
accelerated wound re-epithelization, eschar detachment, neoepidermal formation and enhanced panniculus carnosus (i.e., the
deep striated muscle) reformation compared to their nontransgenic counterparts by 4–7 days post injury (DPI) (Fig. 6a–e).
Interestingly, we observed ectopic anagen HFs within the
hypodermis of 50-day-old Tg(Ctsl-Gdnf)/0 mice after injury when
HFs are expected to be at rest (Fig. 6d’, inset). Importantly,
hemizygous Tg(Ctsl-Gdnf)/0 mice exhibit no baseline difference in
npj Regenerative Medicine (2020) 13

the hair follicle stage (i.e., telogen) when compared to control at
both ages (Fig. 6f). Using uDISCO, we observed increased blood
vessel networks within wounded hemizygous Tg(Ctsl-Gdnf)/0
mice (Fig. 6g, upper right panel). At 18 DPI, we observed
enhanced HF formation at peri-wound regions upon GDNF
overexpression in telogenic mice (Fig. 6g, lower panels), suggesting that GDNF has the potential to inﬂuence either uninjured preexisting or injured/amputated HFs in their recovery. Gene
expression analysis revealed a statistically signiﬁcant increase in
Vegfa transcript in Tg(Ctsl-Gdnf)/0 mice when compared to nontransgenic animals at 1 DPI (Fig. 6h), suggesting early onset of
vascular endothelial cell proliferation mediated by GDNF overexpression. We next appraised wound repair and healing in P50
C57BL/6J mice treated with vehicle (PBS) or recGDNF (50 µg per
Published in partnership with the Australian Regenerative Medicine Institute
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Fig. 6 GDNF overexpression promotes cutaneous wound repair and healing associated with hair formation. a Wound repair in P19 nontransgenic (+/+) mice at 4 DPI. Staining was done with Masson’s trichrome stain (Blue = collagen types, red = keratin and muscle). Scale
bar = 200 µm. b Wound repair in P19 hemizygous Tg(Ctsl-Gdnf )/0 mice at 4 DPI. Masson’s trichrome. Scale bar = 200 µm. c, c’ Wound repair
and healing in P50 non-transgenic (+/+) mice at 4–7 DPI. Masson’s trichrome. Scale bar = 200 µm. d, d’ Wound repair and healing in P50
hemizygous Tg(Ctsl-Gdnf )/0 mice at 4–7 DPI. Masson’s trichrome. Scale bar = 200 µm. e Quantiﬁcation of wound closure in non-transgenic
and hemizygous Tg(Ctsl-Gdnf )/0 mice. Wound size measured at 0–7 DPI: P19 set, non-transgenic, n = 4; hemizygous Tg(Ctsl-Gdnf )/0, n = 7.
P50 set, non-transgenic, n = 6; hemizygous Tg(Ctsl-Gdnf )/0, n = 8. *p ≤ 0.05; error bars = SD, two-way ANOVA with Bonferroni post-hoc test.
f Hair follicle stage within uninjured skin. Masson’s trichrome. Scale bar = 100µm. g Peri-wound hair formation assessed using the uDISCO
clearing method in P50 mice. Wound (W) blood vessel formation depicted at 2 DPI (upper panel). Peri-wound hair formation assed at 18 DPI
(lower panels). h Enhanced Gdnf and Vegfa expression in injured Tg(Ctsl-Gdnf )/0 wounds. Real-time qPCR was performed at 1 DPI using nontransgenic and Tg(Ctsl-Gdnf )/0 wounds. Non-transgenic and hemizygous Tg(Ctsl-Gdnf )/0, n = 5. *p ≤ 0.05, ***p ≤ 0.001; error bars = SD,
Student’s t-test.
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Fig. 7 Recombinant GDNF promotes skin repair and healing after injury. a, b recGDNF accelerates wound re-epithelization and granulation
tissue maturation by 4 DPI. Vehicle-treated wounds depicted by H&E staining (panels a, a”). Epithelial tongue (Ep. t), granulation tissue (Gr),
eschar (es). recGDNF-treated wounds (50 µg/wound) formed the neoepidermis (Neo-ep) by 4 DPI (b). Appearance of vascularized red blood
cells (arrows) within granulation tissue (panel b’). Dermis (D). Scale bars = 200 µm (a, b), and 100 µm (a’–b’). c Recombinant GDNF improves
dorsal skin wound closure by 7 DPI. Single intrawound injection of 33 µM recGDNF (50 µg recGDNF in 100 µl PBS). Vehicle (x injected site).
d, e Improved skin healing after recGDNF treatment by 7 DPI. Masson’s trichrome stain (Blue = collagen types, red = keratin and muscle) of
vehicle-treated wound sections (panel d). Polarized light microscopy of picrosirius red stained control wound sections reveal large parallel
bundles of collagen (arrows) analogous to scar formation (d’). In recGDNF-treated wounds, reduction and maturation of the granulation tissue
with hair follicle (hf ) formation (e), coupled with resolution of scar tissue into interwoven collagen bundles (e’). Scale bars = 200 µm (d, e). See
also Fig. S4. f Restoration of COL4A1 expression in the reticular dermis at the wound site after recGDNF treatment. COL4A1
immunoﬂuorescence staining at 7 DPI (upper panels). The dotted vertical lines encompass the wound region. The papillary (p) dermis is
the uppermost layer of the dermis, while the reticular (r) layer is the lower layer of densely packed collagen ﬁbers. The horizontal dotted line in
the recGDNF-treated sample separates the papillary and reticular dermal layers based on COL4A1 expression. DAPI and COL4A1 merged
images (lower panels). Epidermis (e), hair follicle (hf ). COL4A1 expression of uninjured skin is depicted in Driskell et al. 201337. Scale bars =
200 μm.

intrawound injection) up to 11 DPI. By 4 DPI, treatment with
recGDNF resulted in accelerated re-epithelization of wounds with
concomitant maturation of the granulation tissue to ﬁll the injured
area (Fig. 7). There were increased deposits of vascularized red
blood cells within the recGDNF-treated wound bed when
compared to control (Fig. 7a’, b’). By 7 DPI, the ability of recGDNF
to accelerate wound closure was visually apparent (Fig. 7c).
Histologically, the PBS-treated wounds had yet to fully reepithelialize but contained loosely packed granulation tissue in
the wound bed (Fig. 7d). In contrast, recGDNF-treated wounds
were fully re-epithelialized with neoepidermal detachment from
the overlying eschar (Fig. 7e). In addition, there was shrinkage of
npj Regenerative Medicine (2020) 13

the granulation tissue (i.e., assessed by Trichrome staining) and
appearance of HFs by 7 DPI. We investigated the effect of
recGDNF on collagen ﬁber organization and architecture using
picrosirius red staining coupled with polarized light microscopy to
compare mixed birefringence. We compared multiple collagenenriched regions adjacent to the wound bed (Supplementary Fig.
4), and in PBS-treated wounds we observed large red-orange
birefringent type 1-containing collagen ﬁbers arranged in parallel
scar-like orientation (Fig. 7d’)35. In contrast, after recGDNFtreatment we observed smaller ﬁbers with a mixture of redorange and green birefringence (i.e., indicative of loosely packed
type III collagen35) (Fig. 7e’). Furthermore, the ﬁbers were
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occasionally arranged perpendicular to one another analogous to
uninjured skin (Supplementary Fig. 4c)36. Importantly, the lower
reticular half of the dermal compartment of skin exhibited reemergence of type IV collagen after recGDNF-treatment analogous to uninjured skin compared to PBS-treated wounds (Fig.
7f)37. Collectively, injured skin healed as a scar in controls, while
recGDNF-treatment promoted tissue resolution comparable to
unwounded skin.
GDNF enhances BSC contribution to cutaneous wound closure
We hypothesized that GDNF signaling underlies BSC activation
and commitment of their progenitors to the neoepidermis during
wound repair. To assess the contribution of BSCs and their
progenitors after skin injury, we applied a multicolor lineage
tracing strategy using the K15-CrePR1:R26R-Confetti mouse model.
After K15-speciﬁc Cre-mediated recombination, each cell descendant will stochastically express one of four ﬂuorescent proteins to
generate nuclear GFP, cytoplasmic YFP or RFP, or membranous
CFP-labeled cells38. This system allows for the discrimination
between the clonal progeny of individual cells derived from BSCs
after recGDNF or vehicle treatment over time. After a single topical
application of 1% RU486 to induce Confetti labeling, we wounded
2-month-of-age mice and traced the BSC progeny for 7 days (see
Fig. 8a for an overview). In vehicle-treated animals, relatively few
Confetti-labeled cells were observed closer to the wound margins
and were restricted to the outer non-basal layer of the
neoepidermis within the experimental window (Fig. 8b, left
panel). In corroboration, we observed resting follicles with
Confetti-positive cells restricted to BSC compartments, signifying
relative inactivity after vehicle treatment (Fig. 8b, middle and right
panels). In contrast, recombinant GDNF promoted the activation
and transient commitment of BSC-derived Confetti-labeled cells to
a variety of structures within the neoepidermis, including the
outer differentiated and lower basal layers, by 7 DPI (Fig. 8c left
panel). We frequently detected Confetti-labeled peri-wound HFs
when treated with recGDNF, suggesting that GDNF can activate
resident BSCs, whereby the daughter cells give rise to entire
follicles (Fig. 8c, middle and right panels). Within serial wound
sections, we quantiﬁed the number of uniquely colored ﬂuorescent labels (termed XFPs with a maximum of four), the number
of cohesively associated cells in the same color as clones, and the
number of cells among a single clone within neoepidermal tissues
(Fig. 8d). In vehicle-treated wound samples, we observed on
average 2.2 (±0.1 SEM) XFPs, 3.2 (±0.4 SEM) clones, and 2.0 (±0.2
SEM) cells within individual clones after injury per wound
neoepidermal section. In contrast, recGDNF treatment yielded
on average a statistically signiﬁcant increase of 3.7 (±0.2 SEM; p =
0.003 versus. vehicle) XFPs and 11.3 (±2.6 SEM; p = 0.04 versus.
vehicle) clones, and 1.9 (±0.3 SEM; not signiﬁcant) cells within
clones of the neoepidermal region after injury per section.
BSC-speciﬁc RET deﬁciency leads to impaired cutaneous wound
closure and healing
Because GDNF-mediated signaling within BSCs was found to be
involved in epidermal repair after injury, we hypothesized that
ablation of GDNF signaling within BSCs may inhibit the repair and
healing processes. To test this, we performed skin puncture assays
utilizing the K15-CrePR1:Retﬂox/ﬂox mouse line. We induced Cremediated Ret deletion in 20-day-old mice by topical pretreatment
with 1% RU486 followed by creation of 3 mm full-thickness truncal
wounds (Fig. 9a). We observed a reduction in the underlying hair
in heterozygous K15-CrePR1:Retﬂox/+ mice at 4 DPI (P28) (Fig. 9b).
In control K15-CrePR1:Ret+/+ animals, we macroscopically
observed complete wound closure by 7 DPI; however, K15CrePR1:Retﬂox/ﬂox mice remained incompletely healed by this time
point (Fig. 9c). We observed a statistically signiﬁcant gene dosage
effect on wound size after Ret deletion within BSCs (Fig. 9d).
Published in partnership with the Australian Regenerative Medicine Institute

Relative to controls, we observed a −1.4 ± 0.2 mm2 and −0.6 ±
0.02 mm2 reduction (p = 0.04) in the wound size at 4 DPI within
male homozygous and heterozygous Ret-mutant mice, respectively. Female Ret-mutant mice also showed a similar pattern of
decreased wound closure relative to control mice (i.e., −1.3 ±
0.16 mm2 [homozygous] and −0.7 ± 0.02 mm2 [heterozygous] p =
0.04, respectively). The decrease in wound closure rates in K15CrePR1:Retﬂox/+ and Retﬂox/ﬂox mice was associated with impaired
granulation tissue maturation when compared to control provisional wound matrix at 4 DPI (Fig. 9e). In control wounds, there
was uniform inﬁltration of the granulation tissue assessed by
Trichrome staining (Fig. 9e, middle left panel) that was less
organized in the mutants (Fig. 9e, middle right panel). Compared
to controls, we also observed neoepidermal hypoplasia in K15CrePR1:Retﬂox/ﬂox mice at 4 DPI due to an overall 15 ± 2% decrease
(p = 0.01) in the proliferation of basal keratinocytes (Fig. 9e,
bottom panels). Delayed wound healing persisted up to 7 DPI due
to lack of RET in BSCs, resulting in failure of the eschar to entirely
detach from the neoepidermis, and impaired granulation tissue
resolution with presence of superﬁcial hematoma containing nonvascularized blood cells (Fig. 9f, bottom panel). Overall, RET
signaling promotes the contribution of reparative cells to the
neoepidermis derived from BSCs, whereby genetic ablation of Ret
in BSCs resulted in a concomitant delay in wound repair and
healing processes in mice.
DISCUSSION
Our ﬁndings show that GDNF promotes hair formation and
cutaneous would healing in mice. Both recombinant and
transgene overexpression of GDNF promoted BSC colony growth,
hair formation, and skin repair after wounding, while genetic
ablation of Ret within BSCs prevented the onset of the hair cycle,
the anagen induction of depilated hair follicles, and reduced the
rate of wound closure. GDNF has previously been suggested to
play a role in the natural hair cycle39, however its function within
BSCs has never been tested. Our data show that GDNF protein is
present predominantly within the interfollicular space and in the
vicinity of sebaceous glands, while single-cell sequencing results
from mouse skin reveal that Gdnf transcripts are present in both
bulge hair follicle stem cells, as well as keratinocytes of the
interfollicular epidermis (Joost et al. 2016), suggesting that GDNF
could be acting on more than one cell type within the skin. GDNF
and its receptor GFRA1 are also expressed in human skin and
show an age dependent decline40.
GDNF is known to form a receptor complex with GFRA141 that
signals through RET. We detected GFRA1 expression in BSCs using
a genetic reporter as well as by immunoﬂuorescence. Gfra1
transcript was previously found to be enriched within K15+
BSCs8,29, and Gfra1 transcripts increased during anagen, while
reaching their lowest levels during the resting stage (telogen)39.
Upon stimulation of the hair cycle, Gfra1 transcript reappeared
and increased over time in the natural setting. In the same study39,
GDNF protein was reported to be increased after depilation,
suggesting that GDNF might play a role in anagen induction
within the natural setting. In addition to BSCs, we detected GFRA1expression in Dp cells during the anagen growth phase following
depilation. GDNF signaling within Dp cells may maintain HF
growth, as global Gfra139 and Ret knockout mice (Supplementary
Fig. 5) exhibit premature catagen entry of HFs. However, it is still
unclear if Dp cells are GDNF effector cells. Botchkareva et al. had
postulated that GDNF-GFRA1 signaling within proximal and distal
outer root sheath (ORS) and inner root sheath (IRS) cells of HFs
may play a direct role in blocking premature catagen entry based
on their in situ mRNA expression pattern of Gfra1 and Gdnf39.
Furthermore, Gdnf transcript was shown to peak during the
catagen stage of the hair cycle, further supporting a role in
promoting hair elongation and survival39. However, our studies
npj Regenerative Medicine (2020) 13
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Fig. 8 GDNF signaling improves cutaneous wound repair through expansion and recruitment of hair bulge stem cell epidermal
progenitors in mice. a Experimental design using the K15-CrePR1:R26R-Confetti multi-label reporter line to study the effect of recGDNF on the
fate of cells derived from BSCs after injury. b Commitment of BSC-derived keratinocytes to the injured neoepidermis in vehicle-treated mice.
Neo-epidermis (dotted line) at the wound site marked off by the white vertical bars (left panel). Confetti-labeled keratinocytes (arrows) are
present in the neoepidermis by 7 DPI. Quiescent peri-wound HFs (boxed) that show initial Confetti labeling of BSCs (magniﬁcation) by 7 DPI
(middle and right panels). Bulge (Bg), sebaceous glands (Sg). Scale bars = 200 μm; scale bar (magniﬁcation) = 20 μm. c Recombinant GDNF
promotes the recruitment of BSC progeny to the injured neoepidermis by 7 DPI. Increased migration and commitment of GDNF-stimulated
BSC-derived progeny to the wound neoepidermis (left panel). Cohesive streaks of BSC-descendants recruited to the wound site (middle
panel). GDNF-mediated activation of BSCs (arrow) that give rise to RFP+ cells which deﬁne a HF (right panel). Es (eschar). Scale bars = 200 μm.
d Quantiﬁcation of Confetti-labeled cells in the neoepidermis after injury. Left graph depicts the individual ﬂuorescent proteins (termed XFPs)
observed within the neoepidermis by 7 DPI. Middle graph depicts the number of individual clones (i.e. represented by cohesive single XFPs)
present in the injured neoepidermis. The right graph depicts the number of cells within a clone at the injured neoepidermis. For statistics, a
total of four serial sections through the wound midline were averaged and assessed per mouse at 7 DPI. Vehicle-treated, n = 3 male mice;
recGDNF-treated, n = 4 male mice. *p = 0.04, **p = 0.003; error bars = SEM, two-tailed Student’s t-test. Days post depilation (DPI).

found no evidence of GFRA1 protein within ORS and IRS cells,
suggesting an alternative cellular mechanism which prevents hair
regression by GDNF. Botchkareva et al. also reported that Gfra1
mRNA was absent from Dp cells during all stages of the hair cycle.
npj Regenerative Medicine (2020) 13

However, previous comparative transcriptomic studies revealed
signatures in the Dp cell population of growing hair42, and these
transcripts included Gfra1 (i.e., 9.6-fold increase versus. matrix
cells; 8.6-fold increase versus. ORS cells), which is consistent with
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Fig. 9 Ret ablation within BSCs impairs wound repair and healing in mice. a Schema depicting the experimental design to investigate the
role of RET signaling in BSCs during cutaneous wound healing. Two 3 mm full-thickness skin punctures were administered in the lower truncal
region for each mouse. b Defective hair formation in K15CrePR1:Retﬂox/+ mice. Prior to studying wound healing responses (wounds encircles in
white) by 4 DPI, heterozygous Ret-deﬁcient mice exhibited defects in underlying skin pigmentation after 1% RU486 treatment3. c Impaired
wound closure upon BSC-speciﬁc ablation of RET signaling. Top views of wounds in RU486-induced Ret-ablated mice at 4–7 DPI with results of
surface area calculations. d Quantiﬁcation of cutaneous wound closure upon BSC-speciﬁc Ret deletion relative to control at 4 DPI. For statistics,
we averaged the surface areas for two wounds per mouse by 4 DPI. Males: controls, n = 3; K15-CrePR1:Retﬂox/ﬂox, n = 3; K15-CrePR1:Retﬂox/+,
n = 3. Females: controls, n = 3; K15-CrePR1:Retﬂox/ﬂox, n = 5; K15-CrePR1:Retﬂox/+, n = 3. *p = 0.04; error bars = SEM, two-tailed Student’s t-test.
e Neoepidermal hypoplasia and delayed granulation tissue maturation in injured K15-CrePR1:Retﬂox/ﬂox mice by 4 DPI. Compared to control
mice (left panels), Ret ablation was associated with impaired granulation tissue maturation (outlined in black; upper right panel, boxed region).
Increased thickness of the neoepidermal layer (boxed in yellow) in control wounds compared to Ret-deﬁcient wounds by 4 DPI (middle
panels). Masson’s trichrome stain (Blue = collagen types, red = keratin and muscle). Percentage of Ki67+ proliferative keratinocytes within the
basal layer of the neoepidermis (lower panels). K15CrePR1:Ret+/+, n = 3 serial sections; K15CrePR1:Retﬂox/ﬂox, n = 3 serial sections. *p = 0.01;
error bars = SD, two-tailed Student’s t-test. Bars = 200 μm. Eschar (Es), granulation tissue (Gr), neoepidermis (neo-ep), myoﬁbroblast (myo),
days post injury (DPI). f Skin wound healing defects in K15-CrePR1:Retﬂox/ﬂox mice at 7 DPI. Control wounds have detached eschar from the
neoepidermis (upper panel); however, BSC-speciﬁc Ret-ablated mice fail to detach the eschar (lower panel) (Scale bars = 200 μm). Right panels
depict magniﬁcation of the wound bed (Wb) regions, whereby Ret-mutant wounds exhibit increased red blood cell (Rbc) exudate from
damaged capillaries (Scale bars = 100 μm). Masson’s trichrome stain. Granulation tissue (Gr), hematoma (Hm).
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our ﬁndings. Thus, this raises the possibility that GFRA1 signaling
within other niche cells such as Dp cells may promote the
maturation of HFs as recently shown for Dp sonic hedgehog
signaling43, and whether or not GDNF signaling via Dp cells can
affect wound healing as well.
Conditional ablation of Ret within BSCs prevented the onset of
the hair cycle and anagen induction of depilated hair follicles,
demonstrating the requirement of GDNF-mediated signaling
through RET in BSCs. In contrast, while ablation of Gfra1 among
BSCs impaired the onset of the hair cycle, it had less of an effect
than ablation of Ret, suggesting the possibility that other RETcoupled receptors may be involved in the hair cycle. Other
members of the GDNF family (e.g., neurturin, persephin, and
artemin) can also signal via RET but do so in combination with
other co-receptors (GFRA2-4, respectively)44. Our Gfra1-reporter
assay suggests the involvement of cells that are most likely
affected by GDNF. In our Ret cKO studies, it is possible that the hair
loss associated with Ret ablation may be, in part, also due to
impaired Gfra2-4 and neuturin, persephin, and artemin signaling
as well. However, BSCs neither express Gfra3 and 4 (Supplementary Fig. 6), nor ligands persephin and artemin29. On the contrary,
BSCs do express Gfra229, suggesting the possibility that the
GFRA2-neuturin network may also be compromised upon Ret
ablation in addition to impairment of the GFRA1-GDNF network.
This model is consistent with the unique hair phenotypes
depicted upon either ablation of Gfra1 or Ret within BSCs.
Given the expression of GDNF within the interfollicular
epithelium, we asked whether RET-mediated signaling within
the IFE was important for HF cycling and induced anagen
development. Conditional ablation of Ret within both interfollicular basal epidermal keratinocytes and cells that make up the
outer epithelial layer of HFs33 using a tamoxifen-inducible keratin
14 Cre driver had no observable effect on hair shaft formation or
anagen progression. These observations were conﬁrmed by
quantifying the thickness of the skin, which is an indicator of
the degree of anagen progression3. Overall, our data show that
RET signaling within interfollicular basal epidermal keratinocytes
and outer epithelial cells of HFs is not required for hair cycle
progression and induced anagen development in postnatal mice.
Nonetheless, it is possible that the absence of a phenotype may
have been due to incomplete ablation of Ret within the IFE, or that
GDNF acts on K14-negative cells within the IFE.
We also found that GDNF promotes cutaneous wound healing
and repair by targeting BSCs. By lineage tracing K15+ BSCs after
wounding, we show that one of the modes for GDNF-mediated
cutaneous wound repair is through activation and changes to cell
identity. In contrast, ablation of RET signaling speciﬁcally within
BSCs delayed wound closure after skin injury. This phenotype
points to possible perturbations in BSC numbers, migration, and/
or progenitor commitment to the reconstituted epidermis and
subsequent dysregulation of resident neoepidermal and neighboring cells. Neoepidermal keratinocytes generate and secrete a
number of potent growth factors to properly repair the denuded
wound surface and underlying wound bed in intracrine and
paracrine manners45. Future studies will entail the puriﬁcation,
and molecular and functional characterization of the GDNFprimed cells at the neoepidermis to examine their “reparative and
regenerative” properties in more detail. In addition, from our Ret
knockout animal studies, we provide evidence that GDNF
signaling can also prevent HF regression, although the role of
BSCs versus Dp cells in the process remains unclear. Notwithstanding wounding, damaged HFs endure premature regression
to limit HF growth46, whereby active GDNF-RET signaling may also
enhance survival of peri-wound HFs to improve overall wound
outcomes.
In part, skin wound healing recapitulates morphogenesis, which
entails the initiation of a developmental “reprogramming” cascade
to promote cutaneous lineages that restores tissue integrity and
npj Regenerative Medicine (2020) 13

function to its original state14. In injured adult tissue, scar
formation ultimately results from excess accumulation of an
unorganized ECM, whereby normal ECM architecture is rarely
achieved during the healing process. In contrast to adult wounds,
early gestation fetal skin wounds repair rapidly and heal with the
absence of scar formation47. In fetal wounds, type III collagen is
rapidly deposited in a ﬁne reticular network that is indistinguishable from uninjured skin48. The healing of postnatal wounds
treated with recGDNF or upon GDNF overexpression is reminiscent of fetal wound healing in terms of improved collagen
distribution and HF formation when compared to controls.
Importantly, fetal skin wounds develop a thickened neoepidermis49 compared to adult wounds, further suggesting that GDNF
may stimulate early development-like features of wound repair
and healing in adult mice. Hypothetically, it is possible that the
improved ECM and scar maturation by GDNF may be partially due
to the survival of damaged HFs and/or formation of de novo HFs
following injury. These structures may be able to produce key
biological growth factors that promote the formation of proregenerative cells such as adipocytes and myoﬁbroblasts 50.
Although we focused on the role of GDNF signaling in hair stem
cells during the wounding process, the fact that there was only
partial inhibition of wound closure after Ret ablation suggests the
presence of other cutaneous mediators of the process. Based on
recent single-cell sequencing data of skin tissue29, Gdnf mRNA is
present in both outer bulge stem cell compartment of hair follicles
as well as epidermal cells of the interfollicular epidermis including
basal keratinocytes in mice (Supplementary Fig. 7). These ﬁndings
point toward the possibility that both follicular and extra follicular
sources may be providing GDNF in the skin niche environment to
promote wound healing after injury. Given the known regenerative functions of GDNF upon peripheral nerve injury51 and the
fact that denervated skins in both human and animal models
result in delayed wound repair52, it is possible that GDNF may also
signal via cutaneous innervations to promote wound repair. We
also observed increased vascularization upon GDNF treatment of
cutaneous wounds. Recent studies also support our ﬁndings,
which have shown that GDNF can stimulate capillary-like tube
formation in HUVEC cells in Matrigel53. Furthermore, it was
recently shown that GDNF may promote angiogenesis through
epigenetic regulation of FMOD (ﬁbromodulin)54, a small leucinerich proteoglycan that is positively implicated in wound healing.
Overall, a high dose of GDNF can promote hair growth and wound
healing, however it is remains to be determined if GDNF signaling
in other cell types besides BSCs can play a role in the natural
setting.
METHODS
Mouse strains, breeding, and husbandry
Part of the animal studies were approved by The Jackson Laboratory
Animal Care and Use Committee (Permit Number: 07007) and were in
accordance with the “Guide for the Care and Use of Experimental Animals”
established by the National Institutes of Health (1996, revised 2011). Part of
the animal studies were also approved by the Department of Veterinary
Medicine, Miller School of Medicine at the University of Miami (UM) in
accordance with the UM Animal Care and Use Committee (IACUC protocol
#18-151; Lisse T.S.). Animals were maintained in a 12-h light and 12-h dark
cycle vivarium in the Research Animal Facility at The Jackson Laboratory, as
well as the animal vivarium within the Neuroscience Annex at the
University of Miami. Animals were provided acidiﬁed water (pH 2.8–3.2)
and autoclaved pelleted 5K52 diet (6% fat) ad libitum. In timed pregnancy
crosses, pups were dated based on the presence of vaginal plugs and by
noting the delivery of newly born pups. Wild-type mice used in this study
consisted of C57BL/6J mice (JAX stock no. 000664; RRID:
IMSR_JAX:000664). Animals carrying the GdnfCtsl-REB transgene (i.e., founder
line Tg(Ctsl-Gdnf)4352Reb, referred to as Tg(Ctsl-Gdnf) in the paper) were
generated at the University of Washington and maintained on the C57BL/
6J background20. The Gt(ROSA)26Sortm1(CAG-Brainbow2.1)Cle line (referred to as
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R26R-Confetti38; JAX stock no. 013731) was kept on the C57BL/6J strain.
The Rettm1.2Ddg conditional mutant strain (referred to as Retﬂox 30; JAX stock
no. 028548), in which exons 14 and 15 of the mouse Ret gene were ﬂanked
by loxP sites, was maintained on the C57BL/6J strain. The Tg(Krt1-15-cre/
PGR)22Cot line (referred to as K15-CrePR18; JAX stock no. 005249) was on a
mixed C57BL/6 and SJL background and was used for generation of
RU486-induced, Cre-mediated gene deletions within BSCs of HFs. The Tg
(KRT14-cre/ERT)20Efu/J line (referred to as K14-CreERT; JAX stock no.
005107) was used to generate tamoxifen-inducible gene deletions within
interfollicular epidermal cells of skin. The ﬂoxed Gfra1tm2.1Jmi line (Gfra1EGFP
KO allele with GFP expression; referred to as Gfra1EGFP) has been previously
described23 and was kindly provided by Dr. Sanjay Jain (Washington
University, Saint Louis). A colony of these mice was established following
rederivation by in vitro fertilization of C57BL/6J oocytes and subsequently
maintained on the C57BL/6J background at The Jackson Laboratory. We
obtained heterozygous mice that express the Gfra1 GFP-knock-in allele in a
ubiquitous manner by crossing Gfra1tm2.1Jmi mice to β-actin (ACTB)-cre
mice, herein referred to as Gfra1EGFP/+ or Gfra1Δ/+. The ACTB-Cre line (B6N.
FVB-Tmem163Tg(ACTB-cre)2Mrt/CjDswJ; referred to as ACTB-Cre; JAX stock no.
019099) has been previously described55 and was maintained on the
C57BL/6J background. For conditional deletion of Gfra1, the conditionalready Gfra1tm1.1Wql (Gfra1 ﬂox) line (JAX stock no. 030611)32 was utilized.
RU486 (M8046; 1% w/v in acetone) and tamoxifen (T5648; 20 mg/ml in
corn oil, 100ul per mice; i.p.) were purchased from Sigma–Aldrich.

Genotyping and recombination detection
For mice obtained from The Jackson Laboratory repository, genotyping
was based on established protocols listed on the JAX website for each
stock animal. For genotyping and quantiﬁcation of Tg(Ctsl-Gdnf)
transgenic mice, a PrimeTime® real-time quantitative PCR multiplex assay
(Integrated DNA Technologies, USA) was established with the Life
Technologies ViiA7 RT-qPCR system. We used the PrimeTime® Gene
Expression Master Mix with low reference dye with primer and (double
quench) probe solutions with 50 ng of DNA template. The PCR program
was run according to the manufacturer’s recommendations (Supplementary Table 1). The GdnfCtsl-REB transgene levels were determined by
comparing delta Ct values of each unknown sample against known
homozygous and hemizygous controls with an endogenous reference
(Supplementary Table 1). For Retﬂox genotyping, primers Ret-F (5’-C
CTTGGGCCTGCTGAGCACGGG-3′) and Ret-R (5′-GGAGGCAGGAAGGCCTG
TGC-3′) were used with the PCR program: 95 °C for 3 min, and for 35 cycles
95 °C for 30 s, 66 °C for 30 s, and 72 °C for 40 s. The excised region of the Ret
(ﬂoxed) allele after Cre-mediated recombination (null) was detected using
the primers Ret-F and Ret minus-R (5′-CAAAACACTGTGCTCGCA-3′) to
generate a ~500 bp amplicon using the same PCR program. For Gfra1ﬂox
genotyping, primers Gfra1-F (5′-GGGGCGTAACTGCCAGTCAGC-3′) and
Gfra1-R (5′-GTTTCAGCTCACAGGCCATTGG-3′) were used with the PCR
program: 95 °C for 3 min, and for 35 cycles 95 °C for 30 s, 57 °C for 30 s, and
72 °C for 30 s. The excised region of the Gfra1 (ﬂoxed) allele after Cremediated recombination (null) was detected using the primers Gfra1-F and
Gfra1 minus-R (5′-GACCCAGTTCTGAGTAGGTTG-3′) to generate a 875 bp
amplicon using the same PCR program but with an annealing temperature
of 60 °C.

Hair depilation, wound healing assay, and intrawound delivery of
recombinant GDNF
Under general anesthesia (inhalation isoﬂurane), animals were subjected to
depilation of dorsal hair using Wax Strips (Del Laboratories, Farmingdale,
NY) or shaved to remove hair before tissue collection for analysis. All
procedures were performed using sterile instruments and aseptic
conditions. Experimental mice each received a full-thickness 3 mm
diameter truncal wound with a sterilized biopsy punch device (Sklar
Instruments, PA). Bupivacaine was provided as an analgesic and the
animals were observed daily for any signs of distress. After sacriﬁce, the
degree of re-epithelialization and tissue remodeling was monitored by
harvesting tissue in 4% PFA in PBS (pH 7.4). Intrawound injections of
recombinant Rat GDNF protein (50–125 µg/wound in 50 µl of vehicle
solution; R&D Systems, 512-GF/CF) or 50 µl of vehicle (PBS, 1 mM KH2PO4,
155 mM NaCl, 3 mM Na2HPO4-7H2O, pH 7.4) was administered using a 26gauge needle and syringe. The needle was kept in place for an additional
30 s after injection and then slowly withdrawn.
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Ultimate DISCO (uDISCO) whole-mount passive clearing technique
for skin
To visualize thick skin tissue and hair morphology without sectioning, we
applied the organic solvent-based uDISCO clearing method31. Greater than
3 mm-by-3 mm skin tissues were ﬁxed in 4% PFA at 4 °C overnight.
Samples were washed with 0.1 M PBS and subjected to a tert-butanol
series (70–100%; Sigma–Aldrich, 36053) for gradient dehydration for
2–12 h. Next, dichloromethane (Sigma–Aldrich, 270997) was replaced as a
pure solution for the delipidation step for 1 h at room temperature. A
refractive index matching solution was prepared by mixing BABB (benzyl
alcohol + benzyl benzoate 1:2; Sigma–Aldrich, 24122 and W213802) and
DPE (diphenyl ether) (Sigma–Aldrich, 240834) at a BABB:DPE ratio of 10:1
(vol/vol). The samples were reacted with the BABB:DPE mixture until they
became optically transparent.

Histological and immunoﬂuorescence analysis
Skin tissues were dissected from mice and incubated 2–4 h in 4% PFA at
4 °C before embedding in parafﬁn wax. 7 μm-sections were stained with
hematoxylin and eosin (H&E), Masson’s trichrome and picrosirius reagents
were provided by The Jackson Laboratory Histology Core Services. For
some samples, cryosections were made using a Leica CM 1950 Cryostat.
For immunoﬂuorescence studies, sections were deparafﬁnized in xylene
and rehydrated, the subjected to antigen retrieval for certain antigens (e.g.,
α-Ki67). Tissue sections were blocked in PBS containing 3% normal goat
serum and then incubated with primary antibodies overnight at 4 °C.
Primary antibodies used in this study included: Ki67 (Abcam 16667), KRT15
(Abcam 52816; RRID:AB_869863), RET (Santa Cruz Biotech. Sc167; RRID:
AB_631317), GFRA1 (Santa Cruz Biotech. Sc10716; RRID:AB_2110298), CD31
(Abcam 28364), COL4a1 (Abcam 19808), and GDNF (Santa Cruz Biotech.
Sc328) at 1:200 dilution. Following 3x washes for 5 min each in PBS, the
sections were incubated at room temperature for an hour with
corresponding species-speciﬁc secondary antibodies (Alexa series, Life
Technologies). Following 3× washes in PBS in the dark, sections were
mounted with Vectashield medium containing DAPI (Vector Laboratories)
for nuclei staining. Laser scanning confocal microscopy was performed
using an inverted Olympus FV1000 unit. Z-stacks were obtained from
1–3 µm/slice at a speed of 12.5µs/pixel and then maximally projected. All
other parameters (e.g., pinhole diameter, gain, laser intensities) were kept
constant. Using the FluoView FV1000 imaging software (Olympus), we
obtained orthogonal regions (XY, XZ, or YZ) by placing a crosshair at a
point of interest to obtain a plane along the crosshair lines.

Lineage tracing of hair follicle stem cells after injury with the R26RConfetti reporter line
For K15-CrePR1:R26R-Confetti sample preparation, dorsal hair was removed
with a shaver and wounded skins (2 × 2 cm2) were ﬁxed in 4% PFA in PBS
(pH 7.4) for 2 h. Skin and hair-containing tissues derived from wounds were
cut along the midline and then subjected to graded sucrose treatments
(15–30%) for cryoprotection. These tissues were embedded face down
along the midline in OCT embedding medium (Histolab). Four serial
sections per wound sample were collected and stained with the DRAQ5™
(Thermo Scientiﬁc) far-red DNA ﬂuorescent probe to deﬁne cutaneous
structures such as the neoepidermal boundaries. Sections were then cover
slipped using DAPI-less Vectashield anti-fade mounting medium (Vector
Laboratories) for confocal imaging. Imaging was performed using an LSM
SP8 inverted confocal microscope (Leica) using a 10 × /0.4 multi-immersion
objective. The Confetti ﬂuorescent proteins were detected using the
405 nm (CFP), 488 nm (GFP), 514 nm (YFP) and 561 nm (RFP) lasers, and the
images were acquired at 1024 × 1024 resolution. The 681 nm (DRAQ5) laser
channel was also established, and the super-sensitive HyD detector was
used for low-emitting CFP detection. Initially, laser power and gain were
adjusted manually to provide optimal ﬂuorescence intensity with minimal
photo-bleaching. The step size (1) and line averaging (4) were kept the
same for all samples. Projection of z-stack planes and image analysis were
performed using the IMARIS (Bitplane) software. For the Confetti lineage
tracing parameters, all calculations were based on events which occurred
within the neoepidermal borders between the wound edges. A single
“Confetti” clone was deﬁned as cohesively associated cells of the same
color, whereby the number of cohesively associated cells was the clone
size. The number of individual ﬂuorescent colors (termed XFPs) was also
calculated, whereby the maximal possibilities are four per wound section.
All plots were generated in Prism 3 (Graphpad).
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Bulge stem cell isolation and colony formation assay

DATA AVAILABILITY

In all, ﬁve male C57Bl/6J mice of 53 days of age were used to harvest BSCs.
Dorsal skins were placed on a sylgard plate, cleared of fat, and then
incubated at 37 °C for 120 min with 0.25% trypsin (Gibco). The hair follicles
were scrapped from the skin and transferred to a new culture dish to
prepare a single-cell suspension. The suspension was washed with staining
buffer consisting of 3% Chelexed (Chelex®-100; BioRad) FBS in PBS without
Ca2+ and Mg2+ and kept on ice. The cells were then passed through a
70 µm cell strainer and then a 40 µm cell strainer. 12.5 × 106 cells were
recovered (2.5 × 106/mouse), which were subjected to cell sorting. Spectral
separation of the conjugated antibodies was conﬁrmed using the BD
website, and the antibodies were added to the cells at 1:100 (CD34-FITC;
11-0341-82, Life Technologies) and 1:50 (CD49f-PE/Cyanine7; 313621,
BioLegend) in staining buffer. Mouse BSCs were isolated using a BD
FACSAria II cytometer and analyzed using FACSDiva (ver. 8.0.2) at the
Sylvester Comprehensive Cancer Center (University of Miami Miller School
of Medicine). Appropriate controls were included, and a post-sort analysis
was also performed (Supplementary Fig. 8). In all, 2.5 × 106 BSCs were
puriﬁed from the starting material. For colony formation assays,
approximately 1000 BSCs/cm2 were seeded onto collagen-coated (ALX522-440-0050; Enzo Life Sciences) plates along with mitomycin-treated
NIH/3T3 (CRL-1658; ATCC) feeder cells in Dulbecco’s Modiﬁed Eagle’s
Medium (30-2002; ATCC) with 10% fetal calf serum. BSCs were analyzed in
triplicate and treated with carrier-free recombinant GDNF (01-A0460; ORF
Genetics) reconstituted in sterile PBS. Colonies were imaged on days 3 and
6 using a PrimoVert inverted microscope (Zeiss), and the media was
replaced on day 3. Colony size was determined using ImageJ and the data
was analyzed using Prism (Graphpad).

All data generated during and/or analyzed during the current study are available
from the corresponding author on reasonable request.

RNA isolation and evaluation of gene expression
Total RNA was extracted using the RNeasy Plus minikit (QIAGEN) according
to the manufacturer’s recommendations. Total RNA (1 µg) was reversed
transcribed using the Superscript III ﬁrst-strand synthesis system (Life
Technologies) with random hexamers following the manufacturer’s
recommended conditions. Quantitative real-time PCR (qPCR) was performed using primers designed to span introns based on the latest
genome assembly, GRCm38.p5 (Supplemental Table 2), using the SYBR
Green PCR Master Mix (Applied Biosystems). Measurements were made on
a Life Technologies ViiA7 RT-qPCR system in a 384-well format, and cycling
was followed by melt curve analysis to identify spurious ampliﬁcation.
Target gene expression was normalized to beta-actin mRNA in the same
sample, and relative gene expression was calculated using the method of
Livak and Schmittgen. Statistics were performed using Prism 7 (GraphPad
Software) and analyzed with an unpaired Student’s t-test (error bars are
reported as SEM).

Data analysis
For histomorphometry of homozygous Tg(Ctsl-GDNF) HFs, three serial
sections were used for quantifying the number of anagen HFs present
within a section imaged at ×4 magniﬁcation (i.e., equaling 2 mm). For
histomorphometry of P40 ACTB-Cre:RetΔ/+ mice, each experimental animal
skin was processed for H&E staining and quantiﬁed using three serial
sections followed by an 100 μm interval and repeated three times in all
(nine sections per animal). The total number of HFs was appraised using a
×4 objective (i.e., to obtain a 2 mm ﬁeld of view) of a brightﬁeld
microscope, whereby the data were then converted into percentages of
remaining HFs in the hypodermis. For histomorphometric analysis of K15Cre:Retﬂox/ﬂox mice, four serial sections of skin samples (i.e., to appraise post
depilation and the hair cycle at P29) were used to quantify the number of
anagen IV-VI stage HFs present. We used the ×4 objective for the analysis,
thereby the values represent the average number of follicles present within
a 2 mm section of skin. For K14-Cre:Retﬂox/ﬂox and K15-Cre:Gfra1ﬂox/ﬂox skin
thickness determination, 4–6 serial sections of skin per mice were analyzed
by taking repeated measurements across the span of skin in a blinded
fashion.

Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
npj Regenerative Medicine (2020) 13
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